← McCormick & overview

McCormick & vs JBS: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

McCormick & Company Incorporated (MKC)

Q3 2026
▼2▲1

McCormick's $45B Unilever deal drives 50% share plunge and regulatory review

  • $15.7B Unilever deal crushes shares 50% on leverage fears McCormick's $15.7 billion cash-and-stock purchase of Unilever's food business pushes debt to 4x EBITDA, above its target. Investors fear the huge price paid and heavy borrowing, sending shares down 50% from record highs.

    This is the core new event explaining the massive share decline and investor concern.

  • Reverse Morris Trust structure dilutes existing shareholders The deal uses a Reverse Morris Trust, meaning McCormick issues about $29.1 billion in new shares. Unilever holders end up with roughly 65% of the combined company, leaving current McCormick owners with only 35% and heavy debt.

    Explains the mechanics of dilution that directly pressure the stock price.

  • Berkshire Hathaway interest could ease financing burden Reports suggest Berkshire's new CEO Greg Abel might invest, potentially financing the $16 billion cash need via preferred stock. McCormick's low 9x P/E and 3.7% yield make it attractive, offering a possible counterweight to the selloff.

    Provides a real positive counterweight that could support the stock if financing worries ease.

  • UK regulator opens review, adding deal uncertainty The UK competition watchdog is seeking comments on the merger until August 5. Regulatory scrutiny could delay or alter the deal, keeping a cloud over McCormick shares until the review concludes.

    New regulatory hurdle adds uncertainty that can weigh on the stock in the near term.

July 2026
▼2▲1

McCormick's $45B Unilever deal drives 50% share plunge and regulatory review

  • $15.7B Unilever deal crushes shares 50% on leverage fears McCormick's $15.7 billion cash-and-stock purchase of Unilever's food business pushes debt to 4x EBITDA, above its target. Investors fear the huge price paid and heavy borrowing, sending shares down 50% from record highs.

    This is the core new event explaining the massive share decline and investor concern.

  • Reverse Morris Trust structure dilutes existing shareholders The deal uses a Reverse Morris Trust, meaning McCormick issues about $29.1 billion in new shares. Unilever holders end up with roughly 65% of the combined company, leaving current McCormick owners with only 35% and heavy debt.

    Explains the mechanics of dilution that directly pressure the stock price.

  • Berkshire Hathaway interest could ease financing burden Reports suggest Berkshire's new CEO Greg Abel might invest, potentially financing the $16 billion cash need via preferred stock. McCormick's low 9x P/E and 3.7% yield make it attractive, offering a possible counterweight to the selloff.

    Provides a real positive counterweight that could support the stock if financing worries ease.

  • UK regulator opens review, adding deal uncertainty The UK competition watchdog is seeking comments on the merger until August 5. Regulatory scrutiny could delay or alter the deal, keeping a cloud over McCormick shares until the review concludes.

    New regulatory hurdle adds uncertainty that can weigh on the stock in the near term.

Latest
▼2▲1

McCormick's $45B Unilever deal drives 50% share plunge and regulatory review

  • $15.7B Unilever deal crushes shares 50% on leverage fears McCormick's $15.7 billion cash-and-stock purchase of Unilever's food business pushes debt to 4x EBITDA, above its target. Investors fear the huge price paid and heavy borrowing, sending shares down 50% from record highs.

    This is the core new event explaining the massive share decline and investor concern.

  • Reverse Morris Trust structure dilutes existing shareholders The deal uses a Reverse Morris Trust, meaning McCormick issues about $29.1 billion in new shares. Unilever holders end up with roughly 65% of the combined company, leaving current McCormick owners with only 35% and heavy debt.

    Explains the mechanics of dilution that directly pressure the stock price.

  • Berkshire Hathaway interest could ease financing burden Reports suggest Berkshire's new CEO Greg Abel might invest, potentially financing the $16 billion cash need via preferred stock. McCormick's low 9x P/E and 3.7% yield make it attractive, offering a possible counterweight to the selloff.

    Provides a real positive counterweight that could support the stock if financing worries ease.

  • UK regulator opens review, adding deal uncertainty The UK competition watchdog is seeking comments on the merger until August 5. Regulatory scrutiny could delay or alter the deal, keeping a cloud over McCormick shares until the review concludes.

    New regulatory hurdle adds uncertainty that can weigh on the stock in the near term.

Q2 2026
▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.

June 2026
▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.

▲2▼1

McCormick's strong Q2 earnings beat, but Unilever deal overpay concerns linger

  • Q2 earnings beat and margin expansion McCormick reported Q2 adjusted EPS of $0.80, beating estimates, with sales up 14% and gross margin expanding 270 basis points. This shows the business is performing better than expected, which pushes the stock up.

    This is the main new positive event that directly lifted the stock.

  • Reaffirmed 2026 outlook Management reaffirmed full-year adjusted EPS guidance of $3.05 to $3.13 and sales growth of 13-17%, including the Mexico acquisition. Reassuring guidance reduces uncertainty and supports the stock price.

    Guidance reaffirmation is a key new factor that gives investors confidence.

  • Unilever deal overpay concerns persist Jim Cramer said McCormick is still reeling from its acquisition of Unilever's food business, which Wall Street views as a colossal overpay. This concern weighs on the stock, as investors worry about the high price paid.

    This is a major ongoing negative force that explains why the stock remains under pressure despite good earnings.

JBS N.V. (JBS)

Q3 2026
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

August 2026
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

Latest
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

© 2026 MarketIVWhy